A Real World, Multi-center Study on Mother-to-child Transmission of Hepatitis B Virus in China
Status: Recruiting
Location: See all (15) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY
In order to evaluate the feasibility of eliminating mother-to-child transmission (MTCT) of hepatitis B virus (HBV) by 2030, a multi-center, prospective cohorts study was conducted to investigate MTCT of HBV in China.
Eligibility
Participation Requirements
Sex: Female
Healthy Volunteers: f
View:
• pregnant women with chronic HBV infection.
Locations
Other Locations
China
302 military hospital of China
RECRUITING
Beijing
Beijing YouAn Hospital, Capital Medical University
RECRUITING
Beijing
The First Affiliated Hospital of Jilin University
RECRUITING
Changchun
The First People's Hospital of Foshan
RECRUITING
Foshan
Fifth Affiliated Hospital of Southern Medical University
RECRUITING
Guangzhou
Guangdong Maternal and Child Care Hospital
RECRUITING
Guangzhou
Guangzhou No. 8 People's Hospital
RECRUITING
Guangzhou
Jinlin Hou
RECRUITING
Guangzhou
Zhujiang Hospital, Southern Medical University
RECRUITING
Guangzhou
Xixi Hospital of Hangzhou
RECRUITING
Hangzhou
Third Hospital of Jiujiang
RECRUITING
Jiujiang
Second Hospital of Nanjing
RECRUITING
Nanjing
Shanghai Public Health Clinical Center
RECRUITING
Shanghai
Shenzhen Baoan Maternal and Child Care Hospital
RECRUITING
Shenzhen
The Third People's Hospital of Shenzhen
RECRUITING
Shenzhen
Contact Information
Primary
Jinlin Hou
jlhousmu@163.com
+86 13802727354
Backup
Zhihua Liu
zhihualiu@126.com
+8618665000386
Time Frame
Start Date: 2015-07-01
Estimated Completion Date: 2025-12-31
Participants
Target number of participants: 50000
Treatments
Nationwide hospital-based cohort
HBV-infected mother-infant pairs have been followed from registry to post vaccination serological test (PVST) in hospitals nationwide.
Community-based cohort
HBV-infected mother-infant pairs have been followed from registry to post vaccination serological test (PVST) in Bao' an district, Shenzhen
Related Therapeutic Areas
Sponsors
Collaborators: Chinese Foundation for Hepatitis Prevention and Control, Tigermed Consulting Co., Ltd
Leads: Nanfang Hospital, Southern Medical University